Explore key insights from a comprehensive 1-hour 14-minute lecture on Bruton's Tyrosine Kinase Inhibitors. Delve into the latest developments, clinical applications, and potential impacts of these inhibitors in the field of oncology. Gain valuable knowledge to enhance your understanding of this important class of therapeutic agents and their role in cancer treatment strategies.
Overview
Syllabus
Highlights From Bruton’s Tyrosine Kinase Inhibitors
Taught by
HMP Education
Related Courses
-
Pharmacology - Cancer Drugs – Cell Cycle Inhibitors
-
PARP Inhibitors in Ovarian Cancer Treatment - Webinar - Ambry Genetics
-
PCSK9 Inhibitors in Targeted Treatment of Hypercholesterolemia - April 26, 2016
-
Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
-
Models to Understand and Predict the Clinical Efficacy of Combinations of Cancer Treatment
-
The Drug Development Journey for New Cancer Treatments - Part 2
